Lactoferrin gene polymorphisms in Italian patients with recurrent tonsillitis

International Journal of Pediatric Otorhinolaryngology

Volumn 88, Issue , 2016, Pages 153-156

  Zupin, Luisa ^a   Angelelli, Francesco ^a   Grasso, Domenico Leonardo ^b   Crovella, Sergio ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Genetic polymorphisms; Innate immunity; Lactoferrin; Recurrent tonsillitis

Indexed keywords

LACTOFERRIN; LTF PROTEIN, HUMAN;

AGE DISTRIBUTION; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INNATE IMMUNITY; ITALIAN (CITIZEN); LTF GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SEX DIFFERENCE; TONSILLITIS; CASE CONTROL STUDY; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; IMMUNOLOGY; ITALY;

ALLELES; CASE-CONTROL STUDIES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; IMMUNITY, INNATE; ITALY; LACTOFERRIN; MALE; POLYMORPHISM, GENETIC; RECURRENCE; TONSILLITIS;

EID: 84978112663     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2016.07.002     Document Type: Article

References (41)

1. [1] Nave, H., Gebert, A., Pabst, R., Morphology and immunology of the human palatine tonsil. Anat. Embryol. Berl. 204 (2001), 367–373.
2. [2] Georgalas, C.C., Tolley, N.S., Narula, P.A., Tonsillitis, BMJ Clin. Evid., 2014, 2014.
3. [3] Kvestad, E., Kvaerner, K.J., Roysamb, E., Tambs, K., Harris, J.R., Magnus, P., Heritability of recurrent tonsillitis. Arch. Otolaryngol. Head. Neck Surg. 131 (2005), 383–387.
4. [4] Lindroos, R., Bacteriology of the tonsil core in recurrent tonsillitis and tonsillar hyperplasia–a short review. Acta Otolaryngol. Suppl. 543 (2000), 206–208.
5. [5] Perry, M., Whyte, A., Immunology of the tonsils. Immunol. Today 19 (1998), 414–421.
6. [6] Levay, P.F., Viljoen, M., Lactoferrin: a general review. Haematologica 80 (1995), 252–267.
7. [7] Fine, D.H., Lactoferrin: a roadmap to the borderland between caries and periodontal disease. J. Dent. Res. 94 (2015), 768–776.
8. [8] Metz-Boutigue, M.H., Jolles, J., Mazurier, J., Schoentgen, F., Legrand, D., Spik, G., et al. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem. 145 (1984), 659–676.
9. [9] Powell, M.J., Ogden, J.E., Nucleotide sequence of human lactoferrin cDNA. Nucleic Acids Res., 18, 1990, 4013.
10. [10] Rey, M.W., Woloshuk, S.L., deBoer, H.A., Pieper, F.R., Complete nucleotide sequence of human mammary gland lactoferrin. Nucleic Acids Res., 18, 1990, 5288.
11. [11] Gorr, S.U., Abdolhosseini, M., Antimicrobial peptides and periodontal disease. J. Clin. Periodontol. 38:Suppl 11 (2011), 126–141.
12. [12] Arnold, R.R., Cole, M.F., McGhee, J.R., A bactericidal effect for human lactoferrin. Science 197 (1977), 263–265.
13. [13] Nibbering, P.H., Ravensbergen, E., Welling, M.M., van Berkel, L.A., van Berkel, P.H., Pauwels, E.K., et al. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect. Immun. 69 (2001), 1469–1476.
14. [14] Ellison, R.T. 3rd, The effects of lactoferrin on gram-negative bacteria. Adv. Exp. Med. Biol. 357 (1994), 71–90.
15. [15] Wakabayashi, H., Abe, S., Okutomi, T., Tansho, S., Kawase, K., Yamaguchi, H., Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol. Immunol. 40 (1996), 821–825.
16. [16] Lonnerdal, B., Iyer, S., Lactoferrin: molecular structure and biological function. Annu. Rev. Nutr. 15 (1995), 93–110.
17. [17] Teng, C.T., Factors regulating lactoferrin gene expression. Biochem. Cell Biol. 84 (2006), 263–267.
18. [18] Velliyagounder, K., Kaplan, J.B., Furgang, D., Legarda, D., Diamond, G., Parkin, R.E., et al. One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis. Infect. Immun. 71 (2003), 6141–6147.
19. [19] Jordan, W.J., Eskdale, J., Lennon, G.P., Pestoff, R., Wu, L., Fine, D.H., et al. A non-conservative, coding single-nucleotide polymorphism in the N-terminal region of lactoferrin is associated with aggressive periodontitis in an African-American, but not a Caucasian population. Genes Immun. 6 (2005), 632–635.
20. [20] Wu, Y.M., Juo, S.H., Ho, Y.P., Ho, K.Y., Yang, Y.H., Tsai, C.C., Association between lactoferrin gene polymorphisms and aggressive periodontitis among Taiwanese patients. J. Periodontal Res. 44 (2009), 418–424.
21. [21] Azevedo, L.F., Pecharki, G.D., Brancher, J.A., Cordeiro, C.A. Jr., Medeiros, K.G., Antunes, A.A., et al. Analysis of the association between lactotransferrin (LTF) gene polymorphism and dental caries. J. Appl. Oral Sci. 18 (2010), 166–170.
22. [22] Fine, D.H., Toruner, G.A., Velliyagounder, K., Sampathkumar, V., Godboley, D., Furgang, D., A lactotransferrin single nucleotide polymorphism demonstrates biological activity that can reduce susceptibility to caries. Infect. Immun. 81 (2013), 1596–1605.
23. [23] Excoffier, L., Lischer, H.E., Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under linux and windows. Mol. Ecol. Resour. 10 (2010), 564–567.
24. [24] RcoreTeam, R., A Language and Environment for Statistical Computing. 2015, R Foundation for Statistical Computing, Vienna, Austria http://www.R-project.org/.
25. [25] Sole, X., Guino, E., Valls, J., Iniesta, R., Moreno, V., SNPStats: a web tool for the analysis of association studies. Bioinformatics 22 (2006), 1928–1929.
26. [26] Faul, F., Erdfelder, E., Lang, A.G., Buchner, A., G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39 (2007), 175–191.
27. [27] Scannapieco, F.A., Saliva-bacterium interactions in oral microbial ecology. Crit. Rev. Oral Biol. Med. 5 (1994), 203–248.
28. [28] Lourenco, A.G., Nakao, C., Machado, A.A., Motta, A.C., Tonani, L., Candido, R.C., et al. Lactoferrin, a marker for periodontal disease. Curr. HIV Res. 11 (2013), 220–225.
29. [29] Valimaa, H., Tenovuo, J., Waris, M., Hukkanen, V., Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread. Virol. J., 6, 2009, 53.
30. [30] Stenfors, L.E., Bye, H.M., Vorland, L.H., Remarkable attachment of lactoferrin to streptococcus pyogenes during acute pharyngotonsillitis. Acta Otolaryngol. 121 (2001), 637–642.
31. [31] Doetzer, A.D., Brancher, J.A., Pecharki, G.D., Schlipf, N., Werneck, R., Mira, M.T., et al. Lactotransferrin gene polymorphism associated with caries experience. Caries Res. 49 (2015), 370–377.
32. [32] Doetzer, A.D., Schlipf, N., Alvim-Pereira, F., Alvim-Pereira, C.C., Werneck, R., Riess, O., et al. Lactotransferrin gene (LTF) polymorphisms and dental implant loss: a case-control association study. Clin. Implant Dent. Relat. Res. 17:Suppl 2 (2015), e550–561.
33. [33] Videm, V., Dahl, H., Walberg, L.E., Wiseth, R., Functional polymorphisms in the LTF gene and risk of coronary artery stenosis. Hum. Immunol. 73 (2012), 554–559.
34. [34] Zhou, Y., Wang, W., Zheng, D., Peng, S., Xiong, W., Ma, J., et al. Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes. Med. Oncol. 29 (2012), 1456–1462.
35. [35] Moreno-Navarrete, J.M., Ortega, F.J., Bassols, J., Castro, A., Ricart, W., Fernandez-Real, J.M., Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. Clin. Chem. 54 (2008), 301–309.
36. [36] International HapMap, C., The international HapMap project. Nature 426 (2003), 789–796.
37. [37] Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., et al. A method and server for predicting damaging missense mutations. Nat. Methods 7 (2010), 248–249.
38. [38] Kumar, P., Henikoff, S., Ng, P.C., Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4 (2009), 1073–1081.
39. [39] van Kempen, M.J., Rijkers, G.T., Van Cauwenberge, P.B., The immune response in adenoids and tonsils. Int. Arch. Allergy Immunol. 122 (2000), 8–19.
40. [40] da Silva, B.R., de Freitas, V.A., Nascimento-Neto, L.G., Carneiro, V.A., Arruda, F.V., de Aguiar, A.S., et al. Antimicrobial peptide control of pathogenic microorganisms of the oral cavity: a review of the literature. Peptides 36 (2012), 315–321.
41. [41] Garcia-Montoya, I.A., Cendon, T.S., Arevalo-Gallegos, S., Rascon-Cruz, Q., Lactoferrin a multiple bioactive protein: an overview. Biochim. Biophys. Acta 1820 (2012), 226–236.